Anhco Nguyen
Chief Tech/Sci/R&D Officer at ATARA BIOTHERAPEUTICS, INC.
Net worth: 57 889 $ as of 2024-04-29
Anhco Nguyen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-05-09 | - |
Career history of Anhco Nguyen
Former positions of Anhco Nguyen
| Companies | Position | Start | End |
|---|---|---|---|
| ENUMERAL BIOMEDICAL HOLDINGS INC | Chief Tech/Sci/R&D Officer | 2014-08-03 | 2016-08-16 |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Training of Anhco Nguyen
| University of Washington | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |
- Stock Market
- Insiders
- Anhco Nguyen
- Experience
